SAN FRANCISCO-University of California, San Francisco (UCSF) will establish a state-of-the-art clinical and translational research unit focused on endocrinology at 499 Illinois Street in Mission Bay. With immediate proximity to UCSF’S research campus and three new hospitals, located just one block away, 499 Illinois Street will provide UCSF with a unique advantage in retaining its existing world-class workforce, attracting highly talented scientists and clinicians, and facilitating its continued growth as the nation’s leading university exclusively focused on healthUCSF has signed a 15-year lease for approximately 30,000 rentable square feet (RSF) executed by the developer of 499 Illinois, Alexandria Real Estate Equities, Inc. Given Alexandria’s previous announcement of its long-term lease with Illumina, Inc. at 499 Illinois Street for approximately 97,700 RSF of laboratory/office space, as well as an additional approximately 55,400 RSF currently under negotiation, this approximately 222,780 RSF signature waterfront project is now approximately 82% leased or under negotiation. Market demand for the remaining space at 499 Illinois Street, and Mission Bay more broadly, continues to be solid from multiple segments in life science, translational clinical uses and the rapidly expanding technology and digital health sectors.

With intensifying intellectual and capital investments from UCSF, including the opening of three new, state-of-the-art hospitals (Benioff Children’s Hospital, Cancer Hospital and Women’s Specialty Hospital) in early 2015, Mission Bay continues to enhance its preeminent reputation as an international life science ecosystem comprised of world-class academic, institutional, pharmaceutical, biotechnology, government, and venture capital entities that are collectively developing novel, breakthrough products that will save lives, manage disease and reduce the economic burden of disease on society.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

GlobeSt

Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2024 ALM Global, LLC. All Rights Reserved.